Warning letter
Avlon Industries: warning letter of Jan 23, 2007
FDA warning letter UCM245719 · Center for Drug Evaluation and Research
Key facts
| Reference number | UCM245719 |
|---|---|
| Company | Avlon Industries |
| Subject | Sponsor/Investigator |
| Issue date | Jan 23, 2007 |
| Posted date | Jan 23, 2007 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| CFR sections cited | 56.104, 50.20, 50.25(a), 56.103(a), 312, 312.20, 312.23, 312.50, 312.33(a), 312.33(b)(7), 312.3(b), 312.20(a) and 1 more |
| Country | 3 |
| Inspection city | Melrose Park |
| Inspection ZIP | 60160-1402 |
| Inspection start date | Mar 8, 2006 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: